Critical limb ischemia update and the evolving role of drug-elution technologies

Jared B Hooker1, Beau M Hawkins1

  • 1a Cardiovascular Diseases Section, Department of Internal Medicine , University of Oklahoma Health Sciences Center , Oklahoma City , OK , USA.

Insights

Critical limb ischemia (CLI) treatment advances include drug-eluting therapies. Drug-eluting stents (DES) and drug-coated balloons (DCB) are key for femoropopliteal disease, while angioplasty is standard for below-knee lesions.

Area of Science:

  • Vascular Surgery
  • Interventional Cardiology
  • Endovascular Therapies

Background:

  • Critical limb ischemia (CLI) presents significant cardiovascular mortality and amputation risks.
  • Effective management strategies for CLI are crucial for patient outcomes.
  • Reviewing current epidemiological data and treatment modalities is essential.

Purpose of the Study:

  • To review the epidemiology of critical limb ischemia.
  • To discuss current revascularization options for CLI.
  • To evaluate the role of drug-elution therapies in CLI management.

Main Methods:

  • Literature review of epidemiological studies on CLI.
  • Analysis of revascularization techniques, including surgical and endovascular approaches.
  • Assessment of drug-eluting stents (DES) and drug-coated balloons (DCB) efficacy.

Main Results:

  • Drug-eluting stents (DES) and drug-coated balloons (DCB) demonstrate improved patency in the femoropopliteal segment.
  • These drug-elution therapies are often considered first-line treatments for femoropopliteal disease.
  • For below-knee disease, angioplasty remains the primary strategy, with DES utilized for focal lesions to mitigate restenosis.

Conclusions:

  • Drug-elution therapies offer significant benefits for femoropopliteal critical limb ischemia.
  • Treatment decisions for CLI should be tailored to lesion location and characteristics.
  • Further research may refine the role of DES and DCB in complex CLI cases.
Abstract

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
380
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
472
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
430
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
405
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
420
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
511